| NCT ID | NCT04491344 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Leipzig |
| Condition | Childhood Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2002-01 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2002-01 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to identify polymorphisms that make children and adolescents more prone to obesity and metabolic dysfunction, as well as to identify biomarkers that are linked to causes and consequences of obesity.
Eligibility Criteria
Inclusion Criteria: * all pediatric patients seen in the adiposity outpatient clinic * informed patient consent Exclusion Criteria: * none
Contact & Investigator
Antje Körner, Prof, MD
PRINCIPAL INVESTIGATOR
University of Leipzig
Frequently Asked Questions
Who can join the NCT04491344 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, up to 18 Years, studying Childhood Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04491344 currently recruiting?
Yes, NCT04491344 is actively recruiting participants. Contact the research team at Antje.Koerner@medizin.uni-leipzig.de for enrollment information.
Where is the NCT04491344 trial being conducted?
This trial is being conducted at Leipzig, Germany.
Who is sponsoring the NCT04491344 clinical trial?
NCT04491344 is sponsored by University of Leipzig. The principal investigator is Antje Körner, Prof, MD at University of Leipzig. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.